Bloom Burton & Co. analyst Dave Martin downgraded Repare Therapeutics (NASDAQ: RPTX) from Buy (1) to Hold (3).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE